SPTLC2 is the second SPT-associated gene that underlies monogenic, juvenile ALS and further establishes alterations of sphingolipid metabolism in motor neuron disease pathogenesis. The gene discussed is AGXT; the disease is amyotrophic lateral sclerosis.